BIO-key EMEA Subsidiary Partners with Citadel Global to Expand India Presence and Accelerate Adoption of Biometric Identity Solutions in Support of EU–India Free Trade Agreement

Rhea-AI Summary

BIO-key (NASDAQ: BKYI) announced a planned Mumbai office launch and a strategic value‑added distributor partnership with Citadel Global to expand its India presence, led by BIO-key EMEA, dated Jan 29, 2026. The initiative targets large enterprises, financial institutions, and call centers and aligns with the EU–India free trade agreement to accelerate biometric IAM adoption. Citadel will provide pre-sales, deployment, training, and customer success support while BIO-key’s portfolio (PortalGuard, Passkey:YOU, Identity‑Bound Biometrics, WEB-key) will be delivered via Citadel’s local infrastructure.

Positive

• Announced first India office: Mumbai (Jan 29, 2026)
• Signed strategic VAD partnership with Citadel Global for local go‑to‑market
• Targets large enterprises, financial institutions, and call centers across India
• Plans to deploy BIO-key EMEA portfolio including PortalGuard, Passkey:YOU, IBB, and WEB-key

Negative

• None.

News Market Reaction – BKYI

-4.72%

15 alerts

-4.72% News Effect

+14.5% Peak Tracked

-4.2% Trough Tracked

-$401K Valuation Impact

$8M Market Cap

0.5x Rel. Volume

On the day this news was published, BKYI declined 4.72%, reflecting a moderate negative market reaction. Argus tracked a peak move of +14.5% during that session. Argus tracked a trough of -4.2% from its starting point during tracking. Our momentum scanner triggered 15 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $401K from the company's valuation, bringing the market cap to $8M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Share price: $0.7347 Daily move: 34.07% Trading volume: 173,829,331 shares +5 more

8 metrics

Share price $0.7347 Pre-news price level on 2026-01-29

Daily move 34.07% 24h price change prior to publication

Trading volume 173,829,331 shares Volume on 2026-01-29

20-day avg volume 8,880,854 shares Average daily volume over last 20 sessions

52-week high $1.97 52-week range high

52-week low $0.5088 52-week range low

Warrants registered 6,183,336 shares Shares underlying warrants in Form S-1 resale registration

Potential warrant proceeds $6,307,002.72 Gross cash if all 6,183,336 warrants exercised at $1.02

Market Reality Check

Price: $0.6300 Vol: Volume 173,829,331 is 19....

high vol

$0.6300 Last Close

Volume Volume 173,829,331 is 19.57x the 20-day average 8,880,854, signaling unusually heavy trading ahead of this partnership news. high

Technical Shares at 0.7347 are trading below the 200-day MA of 0.76 and remain 62.71% under the 52-week high of 1.97.

Peers on Argus

BKYI gained 34.07%, while peers showed mixed, mostly single-digit moves: IVDA +5...

BKYI gained 34.07%, while peers showed mixed, mostly single-digit moves: IVDA +5.75%, SPCB +1.96%, GFAI -4.36%, VRME -0.81%, SUGP 0%. No momentum-screener peers were flagged, indicating a stock-specific reaction.

Previous Partnership Reports

5 past events · Latest: Nov 17 (Positive)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Nov 17	Vietnam partnership	Positive	+2.9%	Strategic SAVIS Group partnership to distribute IAM and biometrics across Vietnam.
Nov 12	MEA partnership	Positive	+11.3%	VaporVM deal to expand IAM and biometric solutions across Middle East and Africa.
May 19	Middle East VAD deal	Positive	+0.7%	Cloud Distribution Co. joins as VAD to distribute solutions in Saudi Arabia and region.
Mar 31	Iberia distributor pact	Positive	-3.0%	Arrow ECS Iberia partnership to broaden IAM access in Spain and Portugal.
Mar 13	US education deal	Positive	+5.9%	Ed Tech JPA partnership making PortalGuard available to 195 K-12 institutions.

Pattern Detected

Partnership announcements have typically produced modest single-digit moves, with mostly positive but sometimes negative reactions. Today’s strong 34.07% advance is well above the historical average move of 4.77% for partnership news.

Recent Company History

Recent history shows BIO-key using partnerships to expand geographically and sectorally. Prior deals with Arrow ECS Iberia, Cloud Distribution Co., VaporVM, SAVIS Group, and California’s Ed Tech JPA broadened reach across Iberia, the Middle East, Vietnam, and U.S. education. The new Citadel Global partnership and Mumbai office extend that strategy into India, aligning with the EU–India free trade agreement and continuing BIO-key’s channel-led international expansion.

Historical Comparison

+4.8% avg move · Over the last five partnership announcements, BIO-key’s average move was 4.77%. The current 34.07% r...

partnership

+4.8%

Average Historical Move partnership

Over the last five partnership announcements, BIO-key’s average move was 4.77%. The current 34.07% reaction to the India–Citadel deal stands out as a much larger response.

Partnerships have sequentially extended BIO-key’s IAM and biometric footprint from Iberia and U.S. education into the Middle East, Vietnam, and now India via a dedicated Mumbai presence.

Market Pulse Summary

This announcement details BIO-key EMEA’s new Mumbai office and a distribution partnership with Citad...

Analysis

This announcement details BIO-key EMEA’s new Mumbai office and a distribution partnership with Citadel Global to deliver IAM and biometric solutions in India, aligned with the recent EU–India free trade agreement. It continues a pattern of channel partnerships used to enter regions such as Iberia, the Middle East, and Vietnam. Investors may watch for concrete deployment wins, customer adoption metrics, and how this expansion interacts with existing financing and regulatory developments disclosed in recent SEC filings.

Key Terms

identity and access management, iam, biometric authentication, value-added distributor, +4 more

8 terms

identity and access management technical

"BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM)"

Identity and access management is the set of tools and processes that verify who a person or device is and control what digital resources they can use, like a company’s system for issuing security badges and setting which doors each badge opens. It matters to investors because strong identity controls reduce the chance of costly data breaches, regulatory fines and downtime, protect customer trust, and can lower IT costs and operational risk.

iam technical

"a global leader in Identity and Access Management (IAM) and biometric authentication solutions"

Identity and access management (IAM) is the system and policies a company uses to control who can access its digital systems, data and applications—think of it as the set of keys, locks and visitor rules for a building’s computer network. Strong IAM reduces the risk of data breaches, fraud and regulatory fines, so investors pay attention because weaknesses can lead to costly outages, damage to reputation and legal liabilities that affect a company’s value.

biometric authentication medical

"a global leader in Identity and Access Management (IAM) and biometric authentication solutions"

Biometric authentication uses a person’s unique physical or behavioral traits—such as fingerprints, facial features, iris patterns, or voice—to verify identity instead of passwords or codes. For investors, it matters because faster, more secure login methods can boost customer trust and reduce fraud-related costs, while also creating opportunities and risks around technology adoption, data privacy rules, and the companies that build or supply the biometric systems.

value-added distributor financial

"Citadel Global, a trusted value-added distributor (VAD) with deep expertise in national and enterprise-scale cybersecurity"

A value-added distributor is a middleman that buys products from manufacturers and resells them with extra services such as installation, customization, technical support, training, or bundled software. For investors, a value-added distributor matters because those added services can raise profit margins, create recurring revenue and customer loyalty, and make a company harder to displace—similar to a car dealer that also provides long-term maintenance and upgrades rather than just selling vehicles.

vad financial

"Citadel Global, a trusted value-added distributor (VAD) with deep expertise in national and enterprise-scale cybersecurity"

A ventricular assist device (VAD) is a mechanical pump that helps a failing heart move blood by taking over or supporting one of the heart’s chambers, either temporarily or for the long term. For investors, VADs matter because regulatory approvals, clinical outcomes, manufacturing capacity, and insurance reimbursement directly affect sales potential and costs for companies that develop or sell them; think of a VAD as a booster pump for the heart that can create a predictable medical market opportunity.

free-trade agreement regulatory

"in support of the European Union and India free-trade agreement signed earlier this month"

A free-trade agreement is a formal pact between two or more governments that reduces or removes taxes, quotas and paperwork on goods and services crossing their borders, making it easier and cheaper for companies to sell internationally. For investors, such deals can boost growth prospects for companies with export or import exposure—like lowering costs, opening new markets, and increasing competition—similar to removing tolls on a busy trade highway.

identity-bound biometrics medical

"Identity-Bound Biometrics (IBB), WEB-key biometric engine, and compact authentication devices"

Identity-bound biometrics are physical or biological traits—like fingerprints, facial patterns, iris scans, or DNA—linked directly to a single person and used to prove who they are. For investors, these systems matter because they enable stronger, harder-to-steal authentication for devices, accounts, and transactions (think of a house key that can’t be copied), but they also bring regulatory, privacy and liability risks that can affect adoption, costs and market potential for companies using or selling the technology.

passwordless authentication technical

"PortalGuard® IAM, Passkey:YOU™ passwordless authentication, Identity-Bound Biometrics (IBB)"

Passwordless authentication is a way for users to sign into accounts without typing a traditional password, using alternatives like biometrics (fingerprint or face), a one-time code sent to a device, or a secure link. For investors it matters because it can cut fraud and support regulatory compliance, lower customer support costs tied to password resets, and improve user adoption and retention—factors that can influence a company’s security risk profile and revenue growth.

AI-generated analysis. Not financial advice.

New Mumbai-Based Team and Strategic VAD Partnership will Initially Target Large Enterprise, Financial Institution, and Call Center Digital Identity Needs

MADRID and MUMBAI, India, Jan. 29, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, today announced the planned launch of a Mumbai office, its first in India. This new presence will be staffed by a local team and supported by a newly formed partnership with Citadel Global, a trusted value-added distributor (VAD) with deep expertise in national and enterprise-scale cybersecurity and identity solutions.

The India initiative, led by BIO-key’s Europe, Middle East and Africa (EMEA) subsidiary , is in support of the European Union and India free-trade agreement signed earlier this month. The agreement, the largest-ever trade pact between the two economies, aims to reduce tariffs and deepen economic cooperation across key sectors including services and technology.

BIO-key EMEA’s new India presence positions it to reach and better serve large enterprises, financial institutions, and call center operations across India, empowering them with secure, scalable, and modern IAM and biometric technologies to meet the evolving demands of digital transformation.

The BIO-key EMEA portfolio — including PortalGuard® IAM, Passkey:YOU™ passwordless authentication, Identity-Bound Biometrics (IBB), WEB-key biometric engine, and compact authentication devices — will be delivered through Citadel’s local market infrastructure, which will provide pre-sales engagement, deployment support, training, and customer success services.

“We are excited to partner with BIO-key EMEA to deliver world-class identity and biometric solutions across India and SAARC nations,” said Brejesh Bisht, Sales Director, Citadel Global. “This collaboration brings global expertise together with local execution strength, enabling organizations to fortify their cybersecurity posture and embrace advanced IAM with confidence.”

“India is a pivotal growth market for digital identity and cybersecurity innovation, and the recent EU–India free trade agreement marks a transformative moment for expanded collaboration across technology sectors,” said Alex Rocha, Managing Director – International, BIO-key EMEA. “Our expanded presence in Mumbai, together with our partner Citadel Global, will help Indian enterprises adopt secure IAM and biometric capabilities that support compliance, customer trust, and efficient operations in a rapidly digitizing economy.”

This expansion aligns with a broader strategic push by international partners to strengthen technology ties with India following the India–EU free trade agreement. Hailed as the “mother of all deals” — the trade agreement opens significant opportunities for trade in services and technology and fosters an environment encouraging multilateral investment, innovation, and cooperative growth. 

About Citadel Global (citadelglobal.co)
Citadel Global is a leading provider of enterprise technology solutions, specialising in cybersecurity, identity and access management, and digital transformation services across India and SAARC markets. With a strong focus on technical delivery and customer engagement, Citadel enables organisations to adopt and operationalise advanced security technologies.

About BIO-key EMEA (bio-key.com/international/)
BIO-key Europe, Middle East and Africa (EMEA) is a subsidiary of BIO-key International. BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements, whether as a result of new information, future events, or otherwise.

Engage with BIO-key Corporate
Facebook:	https://www.facebook.com/BIOkeyInternational/
LinkedIn:	https://www.linkedin.com/company/bio-key-international
X:          Investors	@BIOkeyIntl
X:	@BIO_keyIR
StockTwits:	@BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800

FAQ

What did BIO-key (BKYI) announce about its India expansion on Jan 29, 2026?

BIO-key announced a planned Mumbai office launch and a partnership with Citadel Global on Jan 29, 2026. According to BIO-key, the effort is led by BIO-key EMEA and will target large enterprises, financial institutions, and call centers across India.

How will the Citadel Global partnership support BIO-key (BKYI) operations in India?

Citadel Global will act as a local value‑added distributor providing pre-sales, deployment, training, and customer success services. According to BIO-key, Citadel will deliver BIO-key EMEA products through its local market infrastructure.

Which BIO-key products will be offered in India through the Citadel partnership (BKYI)?

BIO-key’s portfolio offered includes PortalGuard IAM, Passkey:YOU passwordless authentication, Identity‑Bound Biometrics, WEB-key engine, and compact devices. According to BIO-key, these solutions will be delivered via Citadel’s local infrastructure and services.

Why is BIO-key (BKYI) timing the India expansion with the EU–India free trade agreement?

BIO-key says the EU–India free trade agreement creates opportunities for services and technology collaboration, enabling expanded market access. According to BIO-key, the agreement supports deeper cooperation and a favorable environment for digital identity solutions.

Which customer segments will BIO-key (BKYI) initially target in India after the expansion?

BIO-key will initially target large enterprises, financial institutions, and call center operations in India. According to BIO-key, these segments were chosen to address digital identity, compliance, and secure authentication needs during digital transformation.